<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" ><channel><title>Targeted Genetics Corporation RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Targeted Genetics Corporation</description>
<link>http://www.alacrastore.com/company-snapshot/Targeted_Genetics_Corporation-1083014</link>
<lastBuildDate>Wednesday, October 15, 2008 8:40:05 PM</lastBuildDate>
<alacra:xlsid>1083014</alacra:xlsid>
<alacra:company>Targeted Genetics Corporation</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/bir/279753</link><guid isPermaLink="false">bir/279753</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Targeted Genetics Corp.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Targeted Genetics Corp.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">RGene Therapeutics Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Develops gene and cell therapy products for the treatment of cystic fibrosis, cancer and infectious diseases.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2836</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">325414</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">B</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">E</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">TGEN</bir:ticker><pubDate>9/18/2008 8:23:49 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">279753</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1912611</link><guid isPermaLink="false">ccbn/T1912611</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen, and welcome to the Targeted Genetics second quarter #### financial results call. Today's presenters are Stewart Parker, President and CEO of Targeted Genetics, and David Poston, Targeted Genetics' Chief Financial Officer. Miss Parker will open today's call with business and clinical highlights for the quarter and close the call with a summary of milestones for the remainder of the year. Her comments will be followed by a financial update from Mr. Poston. The call will then be opened for a question-and-answer session. At this time, all participants are in a listen-only mode. Following today's presentation, instructions will be given for the question-and-answer session. (OPERATOR INSTRUCTIONS.) As a reminder, this call is being recorded today, Wednesday morning, August #, ####. I would now like to turn the call over to Stewart Parker. Please go ahead, ma'am. ...

</description><pubDate>8/6/2008 11:06:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics Q2 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">TGEN</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">7:30am PT</ccbn:time><title>Targeted Genetics Q2 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1912611</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1841114</link><guid isPermaLink="false">ccbn/T1841114</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good morning, ladies and gentlemen, and welcome to the Targeted Genetics' first quarter #### financial results conference call. Today's presenters are Stewart Parker, President and CEO of Targeted Genetics, and David Poston, Targeted Genetics' Chief Financial Officer. Ms. Parker will open today's call with business and clinical highlights for the quarter, and close the call with summary of milestones for the remainder of the year. Her comments will be followed by a financial update from Mr. Poston. The call will then be opened up to questions and answer session. At this time, all participants are in a listen-only mode. Following today's presentation, instructions will be given for the question and answer session. (OPERATOR INSTRUCTIONS). As a reminder this conference is being recorded this Wednesday morning, May #, ####. I'd now like to turn the conference over to Stewart Parker, please go ahead, ma'am. ...

</description><pubDate>5/7/2008 4:12:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Targeted Genetics Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">TGEN</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:30am ET</ccbn:time><title>Q1 2008 Targeted Genetics Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1841114</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1760598</link><guid isPermaLink="false">ccbn/T1760598</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Targeted Genetics at BIO CEO &amp; Investor Conference</description><pubDate>2/12/2008 4:32:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics at BIO CEO &amp; Investor Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">TGEN</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:45pm ET</ccbn:time><title>Targeted Genetics at BIO CEO &amp; Investor Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1760598</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1705287</link><guid isPermaLink="false">ccbn/T1705287</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>12/31/2007 5:21:32 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics Released from FDA Clinical Hold Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">TGEN</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:30am ET</ccbn:time><title>Targeted Genetics Released from FDA Clinical Hold Transcript</title><description>...Good morning, ladies and gentlemen, and welcome to the Targeted Genetics call to discuss the recent FDA decision regarding development of tgAAC## for inflammatory arthritis. Today's presenter is Stewart Parker, President and Chief Executive Officer, and also with us today is Barrie Carter, Executive Vice President and Chief Scientific Officer. After remarks by Ms. Parker the call will be open for a question and answer session. At this time, all participants are in a listen-only mode. (OPERATOR INSTRUCTIONS). As a reminder, this call is being recorded this Monday, November ##, ####. I would now like to turn the conference over to Stewart Parker. Please go ahead, Stewart Parker. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1705287</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1684336</link><guid isPermaLink="false">ccbn/T1684336</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>10/31/2007 5:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Targeted Genetics</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q3 2007 Targeted Genetics Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">TGEN</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:30am ET</ccbn:time><title>Q3 2007 Targeted Genetics Earnings Conference Call Transcript</title><description>...Good morning, ladies and gentlemen, and welcome to the Targeted Genetics third-quarter #### financial results conference call. Today's presenters are Stewart Parker, President and CEO of Targeted Genetics and David Poston, Targeted Genetics Chief Financial Officer. Ms. Parker will open today's call with the business and clinical highlights for the quarter, and her comments will be followed by the financial update from Mr. Poston. The call will be open for a question-and-answer session. At this time all participants are in a listen only mode. Following today's presentation instructions will be given for the question-and-answer session. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded this Wednesday morning, October ##, ####. I would now like to turn the conference over to Stewart Parker. Please go ahead, ma'am. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1684336</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/26746</link><guid isPermaLink="false">srp/26746</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:#### Olive Way, Suite ###, Seattle, Washington ##### Incorporated:WashingtonWeb Site: www.targetedgenetics.comSIC Classification: Biological Products, Except Diagnostic Substances (####) Business Description: Targeted Genetics Corporation develops gene therapy products and technologies for treating both acquired and inherited diseases. ...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">26746</srp:company><title>Targeted Genetics Corporation</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">87612M108</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">TGEN</srp:ticker><pubDate>10/6/2006 12:29:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">26746</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>